HB
Healthcare & Life Sciences
Hepta Bio
United Stateshepta.bio
Hepta Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About Hepta Bio
Hepta Bio is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Hepta Bio develops a liquid biopsy-native AI platform that analyzes epigenetic patterns in cell-free DNA from blood to enable non-invasive diagnosis and monitoring of chronic liver diseases such as metabolic dysfunction-associated steatohepatitis (MASH).
Explore Hepta Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.